Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes
Sign Up to like & getrecommendations! Published in 2019 at "Hormone Molecular Biology and Clinical Investigation"
DOI: 10.1515/hmbci-2018-0063
Abstract: Abstract Background Irisin and fibroblast growth factor 1 (FGF1) are intricately involved in metabolic syndrome (MetS) and prediabetes (preDM) pathophysiology. This study aimed to compare and correlate irisin and FGF1 plasma levels, adiposity, atherogenicity and… read more here.
Keywords: index; adiposity; hdl; irisin ... See more keywords